CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

/C O R R E C T I O N - AbbVie/

ConferenceNeutral
AI Analysis

Summary

AbbVie issued a correction to its 18-Oct-2026 news release about data to be presented at the 2026 ESMO Congress highlighting its solid tumor portfolio. The excerpt does not specify what changes were made.

Importance:3/10
Sentiment:
0.00
correctionESMO 2026oncologysolid tumorsconference presentation
Related Companies

Read the original article

Published by PR Newswire Biotech on October 19, 2026 1:18 AM

Read Original